Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Rapid uptake of nanoparticles by mononuclear phagocyte system (MPS) significantly hampers their therapeutic efficacy. Temporal MPS blockade is one of the few ways to overcome this barrier – the approach rediscovered many times under different names but never extensively used in clinic. Using meta-analysis of the published data we prove the efficacy of this technique for enhancing particle circulation in blood and their delivery to tumours, describe a century of its evolution and potential combined mechanism behind it. Finally, we discuss future directions of the research focusing on the features essential for successful clinical translation of the method.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002 · cited 3×
“3j) 4 , or rapid drug unloading in the tumour-surrounding microenvironment 95 .”
BackgroundComplement and its role in innate and adaptive immune responses
Dunkelberger, J. R., & Song, W.-C. (2010) · Cell Research · doi:10.1038/cr.2009.139 · Cited by 1,932 · cited 1×
“Additionally, the blockade may indirectly hamper adaptive immunity by depleting involved opsonins 104 or impairingantigenpresentationtoBcells 105 .”
BackgroundThe entry of nanoparticles into solid tumours
Sindhwani, S., Syed, A. M., Ngai, J., Kingston, B. R., Maiorino, L., Rothschild, J., MacMillan, P., Zhang, Y., Rajesh, N. U., Hoang, T., et al. (2020) · Nature Materials · doi:10.1038/s41563-019-0566-2 · Cited by 1,732 · cited 1×
“It is commonly considered that nano-particles can accumulate in tumours via leaky vasculature due to enhanced permeability and retention (EPR) effect 96 or using active transendothelial processes of transport 97 .”
BackgroundAnselmo, A. C., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10003 · Cited by 1,321 · cited 1×
“In fact, it is predominantly liposomal and protein-based formulations that demonstrated clinical success, particularly for the treatment of tumours 3 .”
BackgroundPhagocytosis: An Immunobiologic Process
Gordon, S. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.026 · Cited by 902 · cited 1×
“Phagocytosis appears to be a predominant mechanism of nanoparticle internalisation by macrophages in vivo 73 , although caveolin-and clathrin-dependent endocytosis are also involved.”
BackgroundThe accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
Abu Lila, A. S., Kiwada, H., & Ishida, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.026 · Cited by 721 · cited 1×
“However, the broad applicability of these methods is hindered by the complexity of optimisation and management of potential side effects 12 – 14 .”
BackgroundAnatomy of rodent and human livers: What are the differences?
Kruepunga, N., Hakvoort, T. B. M., Hikspoors, J. P. J. M., Köhler, S. E., & Lamers, W. H. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.05.019 · Cited by 79
Cited by
Wang, K., Yang, R., Li, J., Wang, H., Wan, L., & He, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1591438 · Cited by 27
“Nanocarriers are designed to cross the BBB and deliver therapeutic agents to the CNS, but their accumulation in non-target tissues or the brain could lead to toxicity or diminish their therapeutic ef fi cacy (Blanco et al., 2015; Zelepukin et al., 2024).”
Tanaka, M., Araujo, A. C., Valenti, V. E., Guiguer, E. L., Catharin, V. C. S., Gualhardi, C. M., de Souza Bastos Mazuqueli Pereira, E., de Alvares Goulart, R., de Argolo Haber, R. S., de Carvalho, A. C. A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052370 · Cited by 13
Metadata
- Authors
- Zelepukin, I. V., Shevchenko, K. G., & Deyev, S. M.
- Venue
- Nature Communications
- Published
- 2024-05-22
- Volume
- 15
- Issue
- 1
- Pages
- 4366-4366
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W4398197650
- Cited by
- 224
- References
- 8
- FWCI
- 18.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery. https://app.cochat.ai/papers/10.1038/s41467-024-48838-5
- The paper
- Zelepukin, I. V., Shevchenko, K. G., & Deyev, S. M. (2024). Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery. Nature Communications. https://doi.org/10.1038/s41467-024-48838-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.